High risk HB criteria include patients with preoperative PRETEXT IV, serum AFP < 100 ng/ml, distant metastasis at diagnosis, invasion of the portal vein, inferior vena cava or hepatic vein and tumor rupture or intraperitoneal hemorrhage (4, 16). This evidence concerns the gene AFP and hemoglobin measurement.